Adolescent and Young Adult (AYA) Oncology in the United States: A Specialty in Its Late Adolescence

  title={Adolescent and Young Adult (AYA) Oncology in the United States: A Specialty in Its Late Adolescence},
  author={Peter H Shaw and Damon R. Reed and Nicholas D. Yeager and Brad Zebrack and Sharon M Castellino and Archie Bleyer},
  journal={Journal of Pediatric Hematology/Oncology},
Over the last 30 years, it has become apparent that oncology patients ages 15 to 39 have not reaped the same rewards of improved survival that we have seen in younger and older patients. As a result, in 2006 the Adolescent and Young Adult (AYA) Oncology Progress Review Group convened and examined the factors that impact the care of the 70,000 new cases per year (approximately 7% of all new cases) in the United States and published their findings. The reasons for inferior survival gains are of… 

Disparities in Adolescents and Young Adults With Cancer

Recent progress in AYA patient care is discussed and remaining disparities that exist are highlighted, including financial disadvantages, need for fertility care, limited clinical trial availability, and other areas of evolving AYA-focused research are highlighted.

AYA Considerations for Aggressive Lymphomas

There is an urgent need for clinical trials including AYAs in order to increase the knowledge of age-specific outcomes, toxicities, disease biology, and the need to develop comprehensive AYA care models that meet the unique and complex care needs of this patient population.

Adolescent and young adult lymphoma: collaborative efforts toward optimizing care and improving outcomes.

An in-depth discussion of lymphoma management across pediatric and adult oncologic disciplines, focusing on Hodgkin lymphoma, mature B-cell lymphomas, and anaplastic large cell lymphoma is presented.

Palliative Care in Adolescents and Young Adults With Cancer.

The emerging trend toward standardizing oncology care to meet the unique medical, psychosocial, and supportive care needs of AYA patients with cancer and their families represents an opportunity for health care professionals to collaborate early with palliative care specialists to control symptoms and relieve suffering in this vulnerable population.

Survival after cancer in children, adolescents and young adults in the Nordic countries from 1980 to 2013

It is suggested that in an affluent setting with free access to healthcare, meaningful differences in survival between AYA patients and either childhood or adult patients are a phenomenon of the past for most AYA cancer diagnostic groups.

Trends in Cancer Mortality Among Adolescents and Young Adults in Brazil.

The aim of this study was to evaluate the trends in cancer mortality of AYA aged 15–29 years in Brazil and found that survival among this group has not improved as much as in younger children with cancer.

Outcomes of Lymphoma Among American Adolescent and Young Adult Patients Varied by Health Insurance—A SEER-based Study

No or insufficient insurance was linked to poor OS in the authors' sample in exposure-outcome association analysis, suggesting insurance coverage and health care availability may enhance disparate outcomes of AYAs with cancer.

Enrollment of adolescents and young adults onto SWOG cancer research network clinical trials: A comparative analysis by treatment site and era

Few adolescents and young adults (AYAs, 15‐39 years old) enroll onto cancer clinical trials, which hinders research otherwise having the potential to improve outcomes in this unique population. Prior

The feasibility and value of parent input when evaluating the mental health of young adults with and without cancer

Whether the K-SADS-PL could be extended to young adults 18 to 25 with and without cancer by assessing the feasibility of obtaining parent interviews, and furthermore, whether parent interviews improved the detection of mental health symptoms compared with young adult interviews alone.

Advance Care Planning Discussions with Adolescent and Young Adult Cancer Patients Admitted to a Community Palliative Care Service: A Retrospective Case-Note Audit.

The results indicate that end-of-life care preferences for this unique cohort may differ from those of the adult population and need to be captured and understood.



A Comparison of Clinical Trial Enrollment Between Adolescent and Young Adult (AYA) Oncology Patients Treated at Affiliated Adult and Pediatric Oncology Centers

The authors' data demonstrate that clinical trial enrollment was superior when AYA patients were treated at a pediatric cancer center, and this may partly explain why their cure rates have not improved as significantly as younger pediatric oncology patients.

How NCCN guidelines can help young adults and older adolescents with cancer and the professionals who care for them.

  • A. Bleyer
  • Medicine
    Journal of the National Comprehensive Cancer Network : JNCCN
  • 2012
The NCCN Guidelines for Adolescent and Young Adult Oncology provide specific algorithm-based care recommendations for 15- to 39-year-olds with cancer, who as an age group have the greatest potential patient-years of life to be saved.

Patterns of Care Among Adolescents With Malignancy in Ohio

Specific diagnosis, age, and geographic location influence the site of treatment of adolescent patients, and efforts to improve survival and increase enrollment in clinical trials must take these factors into account.

Adolescents and young adults with cancer

The participation rate in cancer treatment trials has been strikingly lower in 15–34‐year‐olds than in younger or older patients, and the national cancer mortality reduction and SEER survival improvement shows a similar age dependence.

Recruitment of adolescents and young adults to cancer clinical trials--international comparisons, barriers, and implications.

The last 30 years have seen significant improvements in survival rates for children and older adults. In contrast, the 5-year survival rate among 20 to 39 year olds has been static at around 70%

Cancer in older adolescents and young adults: epidemiology, diagnosis, treatment, survival, and importance of clinical trials.

  • W. Bleyer
  • Medicine
    Medical and pediatric oncology
  • 2002
The 5-year outcome in 15-19 year olds with leukemias and sarcomas is not only worse than in younger patients, but also lower in this population at large than in patients of the same age treated at Children's Cancer Group institutions.

Young Adult Oncology: The Patients and Their Survival Challenges

  • A. Bleyer
  • Medicine, Psychology
    CA: a cancer journal for clinicians
  • 2007
Whereas the 15‐ to 29‐year age group once had a better overall survival rate than either younger or older patients, a relative lack of progress has resulted in the majority of cancers in the age group having a worse overall survival rates than in younger patients, and several of theseHaving a worse prognosis than in older patients.

Adolescent and young adult oncology. Clinical practice guidelines in oncology.

The recommendations for age-appropriate care outlined in these NCCN Guidelines include psychosocial assessment, a discussion of infertility risks associated with treatment and options for fertility preservation, genetic and familial risk assessment for all patients after diagnosis and palliative care and end-of-life considerations for patients for whom curative therapy fails.

Clinical trial participation and time to treatment among adolescents and young adults with cancer: does age at diagnosis or insurance make a difference?

The study identified factors associated with low clinical trial participation in AYA patients with cancer and support the continued need to improve access to clinical trials and innovative treatments for this population, which may ultimately translate into improved survival.